Edition:
India

Stellar Biotechnologies Inc (SBOT.OQ)

SBOT.OQ on NASDAQ Stock Exchange Capital Market

1.73USD
1:30am IST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.73
Open
$1.74
Day's High
$1.74
Day's Low
$1.70
Volume
7,788
Avg. Vol
146,123
52-wk High
$10.43
52-wk Low
$1.65

Chart for

About

Stellar Biotechnologies, Inc. is a biotechnology company. The Company is engaged in the aquaculture, research and development, manufacture and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-target... (more)
No analyst recommendations are available for .

Overall

Beta: 2.30
Market Cap(Mil.): $15.16
Shares Outstanding(Mil.): 10.52
Dividend: --
Yield (%): --

Financials

Cryptocurrency firm Stellar gets Islamic finance certification

SYDNEY California-based Stellar has received certification from Islamic scholars for its blockchain platform and related cryptocurrency, aiming to integrate the technology into the field of sharia-compliant financial products.

17 Jul 2018

Cryptocurrency firm Stellar gets Islamic finance certification

SYDNEY California-based Stellar has received certification from Islamic scholars for its blockchain platform and related cryptocurrency, aiming to integrate the technology into the field of sharia-compliant financial products.

17 Jul 2018

Cryptocurrency firm Stellar gets Islamic finance certification

SYDNEY, July 17 California-based Stellar has received certification from Islamic scholars for its blockchain platform and related cryptocurrency, aiming to integrate the technology into the field of sharia-compliant financial products.

17 Jul 2018

BRIEF-Stellar Acquisition Reduces Extension Date Of Initial Business Combination To August 24

* STELLAR ACQUISITION III INC. ANNOUNCES INCREASE IN MONTHLY CONTRIBUTION AMOUNT TO TRUST ACCOUNT POST-EXTENSION APPROVAL AND SHORTENING OF EXTENSION DATE TO AUGUST 24, 2018 Source text for Eikon: Further company coverage:

15 May 2018

BRIEF-Stellar Biotechnologies Announces Pricing Of $5.5 Mln Public Offering

* STELLAR BIOTECHNOLOGIES ANNOUNCES PRICING OF $5.5 MILLION PUBLIC OFFERING

11 May 2018

BRIEF-Stellar Biotechnologies Reports Q2 Loss Per Share Of $0.90

* STELLAR BIOTECHNOLOGIES REPORTS SECOND QUARTER FINANCIAL RESULTS

07 May 2018

BRIEF-Stellar Biotechnologies Announces One-For-Seven Reverse Split

* STELLAR BIOTECHNOLOGIES ANNOUNCES ONE-FOR-SEVEN REVERSE SPLIT

28 Apr 2018

BRIEF-Stellar Biotechnologies Reports Q1 Loss Per Share $0.13

* STELLAR BIOTECHNOLOGIES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

08 Feb 2018

BRIEF-Stellar Biotechnologies Appoints Pharma Licensing Expert To Board Of Directors

* STELLAR BIOTECHNOLOGIES APPOINTS PHARMA LICENSING EXPERT TO BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

25 Jan 2018

Earnings vs. Estimates

No consensus analysis data available.